Stability Indicating Method for the Assay of Remogliflozin Etabonate and its Related Substances by RP-HPLC-Reference-Cited by-同舟云学术

Stability Indicating Method for the Assay of Remogliflozin Etabonate and its Related Substances by RP-HPLC

Published:2023-01-02 Issue:1 Volume:13 Page:73-81
ISSN:2229-7928
Container-title:Analytical Chemistry Letters
language:en
Short-container-title:Analytical Chemistry Letters

Author:

Yadav Ramji Lal¹,Dev Rahul¹,Santra Ruchita²,Jain Priti²

Affiliation:

1. Mankind Research Centre, Manesar, Gurugram, India

2. School of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Delhi Pharmaceutical Sciences and Research University, New Delhi-110017, India

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/22297928.2023.2176785

Reference14 articles.

1. Remogliflozin etabonate: a novel SGLT2 inhibitor for treatment of diabetes mellitus

2. Remogliflozin Etabonate, in a Novel Category of Selective Low-Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors, Exhibits Antidiabetic Efficacy in Rodent Models

3. PubChem, “Remogliflozin etabonate”, https://pubchem.ncbi.nlm.nih.gov. Accessed 18 Sept 2020.

4. ChEMBL, “Remogliflozin etabonate”, https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2028665/. Accessed 18 Sept 2020.

5. Product information of remogliflozin A by Cayman Chemicals, Accessed 18 Sept 2019.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stability-indicating green HPLC method for fixed-dose tablets containing remogliflozin etabonate and teneligliptin: an AQbD approach;Drug Development and Industrial Pharmacy;2024-09-11

2. Stability-indicating HPLC for remogliflozin, vildagliptin, and metformin: Method development, validation, and greenness;Annales Pharmaceutiques Françaises;2024-06

3. Charge transfer based green spectrophotometric method to determine remogliflozin etabonate applying response surface methodology supported with computational studies in pharmaceutical formulations;Sustainable Chemistry and Pharmacy;2023-10